Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-20

Clinical Trial Update: A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update on long-term use of valsartan in young children with hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2021-05-20